FTC Sues Ovation Over Alleged Monopoly On Prescription Drugs For Infants
The Federal Trade Commission on Tuesday filed a lawsuit in U.S. District Court in Minneapolis over allegations that Ovation Pharmaceuticals sought to form a monopoly on the two medications for patent ductus arteriosus, a life-threatening heart condition in infants, and increased the price of the treatments by 1,300%,
More: continued here
Filed under: Medical Malpractice / Litigation on December 19th, 2008